FADINI, GIAN PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 23.199
EU - Europa 2.469
AS - Asia 1.981
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 10
OC - Oceania 8
AF - Africa 5
Totale 27.688
Nazione #
US - Stati Uniti d'America 23.177
CN - Cina 1.318
IT - Italia 753
FI - Finlandia 426
SE - Svezia 393
SG - Singapore 370
DE - Germania 308
GB - Regno Unito 258
VN - Vietnam 147
UA - Ucraina 145
IN - India 75
IE - Irlanda 66
FR - Francia 50
NL - Olanda 29
CA - Canada 19
JP - Giappone 18
EU - Europa 16
HK - Hong Kong 16
GR - Grecia 9
ES - Italia 6
IR - Iran 6
KR - Corea 6
TR - Turchia 6
BG - Bulgaria 5
BR - Brasile 5
AU - Australia 4
NZ - Nuova Zelanda 4
MX - Messico 3
RO - Romania 3
RU - Federazione Russa 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
GA - Gabon 2
ID - Indonesia 2
PK - Pakistan 2
PT - Portogallo 2
QA - Qatar 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AR - Argentina 1
AT - Austria 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IQ - Iraq 1
LU - Lussemburgo 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
VE - Venezuela 1
Totale 27.688
Città #
Fairfield 4.269
Woodbridge 2.550
Houston 2.237
Ann Arbor 1.769
Chandler 1.702
Ashburn 1.631
Seattle 1.551
Cambridge 1.493
Wilmington 1.325
Jacksonville 680
Princeton 463
San Diego 421
Roxbury 311
Beijing 294
Medford 274
Des Moines 224
Singapore 224
Padova 208
Helsinki 193
Nanjing 172
Guangzhou 157
Boardman 151
Dong Ket 146
New York 98
Shanghai 94
Shenyang 76
Dearborn 72
Dublin 64
Hebei 58
Nanchang 57
Jinan 56
Milan 53
London 51
Jiaxing 35
Changsha 34
Redwood City 34
Rome 34
Tianjin 33
Ogden 31
Hefei 30
Norwalk 27
Los Angeles 26
Kunming 24
Zhengzhou 24
Denver 22
Pune 20
Kharkiv 18
Paris 16
Redmond 16
Borås 14
Tappahannock 14
Kilburn 13
Selvazzano Dentro 13
Falls Church 12
Hangzhou 12
Lappeenranta 12
Munich 12
Este 11
Lessolo 11
Ningbo 11
Sommacampagna 11
Indiana 10
Taizhou 10
Chicago 9
Chiswick 9
Rockville 9
Vicenza 9
Bologna 8
Duncan 8
Lanzhou 8
Washington 8
Dallas 7
Fuzhou 7
Haikou 7
Wandsworth 7
Amsterdam 6
Breganze 6
Cagliari 6
Chengdu 6
Detroit 6
Florence 6
Hyderabad 6
Islington 6
Ottawa 6
Groningen 5
Moncalieri 5
Napoli 5
Phoenix 5
Prescot 5
Treviso 5
Venice 5
Xian 5
Auburn Hills 4
Bari 4
Boston 4
Guiglia 4
Hounslow 4
Manoppello 4
Naples 4
New Delhi 4
Totale 23.936
Nome #
Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence 327
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 188
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 186
NETosis delays diabetic wound healing in mice and humans 170
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 169
Loss of mitochondrial calcium uniporter rewires skeletal muscle metabolism and substrate preference 159
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 158
Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients 155
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 155
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 154
Phenotypic activation and pharmacological outcomes of spontaneously differentiated human monocyte-derived macrophages. 153
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 152
Mitochondrial Calcium Uptake Is Instrumental to Alternative Macrophage Polarization and Phagocytic Activity 147
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 145
High temporal resolution detection of patient-specific glucose uptake from human ex vivo adipose tissue on-chip. 143
NETosis is induced by high glucose and associated with type 2 diabetes. 142
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 141
Clones of Interstitial Cells From Bovine Aortic Valve Exhibit Different Calcifying Potential When Exposed to Endotoxin and Phosphate 138
Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment in Vitro and Impaired by Menopausal Status. 137
Carotid Plaque Calcification Predicts Future Cardiovascular Events in Type 2 Diabetes 135
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 135
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 134
Sarcoidosis is a Th1/Th17 multisystem disorder 130
Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization? 130
The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications. 130
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 128
Endothelial progenitor cells as resident accessory cells for post-ischemic angiogenesis. 127
Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. 125
A perspective on NETosis in diabetes and cardiometabolic disorders 125
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. 124
An underlying principle for the study of circulating progenitor cells in diabetes and its complications. 124
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 123
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. 122
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 121
At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways 120
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1 120
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients 120
Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia 120
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 120
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 120
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 119
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. 118
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 116
Cross-talk of healthy and impaired human tissues for dissection of disease pathogenesis 116
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 116
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System 115
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 114
DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors 114
Characterization of endothelial progenitor cells 113
The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells. 113
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. 113
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 112
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 112
Improved function of circulating angiogenic cells is evident in type 1 diabetic islet-transplanted patients. 110
Endothelial progenitor cells and the diabetic paradox. 110
High confidence and sensitivity four-dimensional fractionation for human plasma proteome analysis. 110
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 110
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 110
Impaired hemodynamic response to meal intake in insulin-resistant subjects: an impedance cardiography approach 110
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study 110
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. 109
Prediabetes influences cardiac rehabilitation in coronary artery disease patients. 109
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 109
Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice 108
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study 108
Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications 107
Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis. 106
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 106
The peritoneum as a natural scaffold for vascular regeneration. 106
Vascular smooth muscle cells and monocyte-macrophages accomplice in the accelerated atherosclerosis of insulin resistance states 106
Exploring interactions among metabolic syndrome traits. Methods and meaning. 105
The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk 104
High Abundance Proteins Depletion vs Low Abundance Proteins Enrichment: Comparison of Methods to Reduce the Plasma Proteome Complexity 103
Development of a multiphoton-multicolor and super-resolution STED microscope for in vivo experiments 103
Diabetes Limits Stem Cell Mobilization Following G-CSF but not Plerixafor. 102
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 102
Comparative effectiveness of liraglutide in the treatment of type 2 diabetes. 101
The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing 101
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 101
Endothelial progenitor cells in the natural history of atherosclerosis 101
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 101
Developmental cardiovascular biology meets regenerative medicine at Islet-1. 101
Pharmacologic targeting of endothelial progenitor cells. 100
Synergistic Interactions Among Metabolic Syndrome Components and Homeostasis Model Assessment of Insulin Resistance in a Middle-Aged General Population over Time. 100
Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance 99
17beta-estradiol modulates monocyte heterogeneity and macrophage polarization 99
Oxidative stress and vascular disease in diabetes: Is the dichotomization of insulin signaling still valid? 98
Increased tissue endothelial progenitor cells in end-stage lung diseases with pulmonary hypertension. 98
Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. 98
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures 98
A perspective on sirtuins in the metabolic syndrome. 98
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 97
Endothelial progenitor cells in diabetes mellitus. 97
Persistent reduction of circulating myeloid calcifying cells in acromegaly. Relevance to the bone-vascular axis 97
Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: A case-control study 96
Is the metabolic syndrome a cardiovascular risk factor beyond its specific components? 95
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. 95
A reappraisal on the role of circulating (progenitor) cells in the pathobiology of diabetic complications 95
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans. 95
A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. 94
Totale 12.061
Categoria #
all - tutte 103.162
article - articoli 98.527
book - libri 437
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 156
Totale 202.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.779 698 192 89 523 586 478 711 644 626 542 373 317
2020/20215.510 257 340 218 395 273 476 226 426 712 977 609 601
2021/20225.300 203 552 698 329 282 327 252 591 318 123 511 1.114
2022/20233.508 748 376 76 455 492 437 38 252 416 43 144 31
2023/20242.081 79 297 235 149 111 224 159 78 87 243 205 214
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 28.072